{"entity":{"type":"insider","cik":"0001299065","url":"/insider/0001299065","json_url":"/insider/0001299065.json","name":"Barlow David S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":133,"n_filings":15,"first":"2005-08-23","last":"2011-01-28","span_basis":"filed_date"},"name_variants":[{"name":"Barlow David S","source":"filing","n_filings":15,"first_seen":"2005-08-23","last_seen":"2011-01-28"}],"transactions":[{"id":8870144,"accession":"0001299065-11-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001299065-11-000001","line_url":"/filing/0001299065-11-000001","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59000.0,"shares_display":"59,000","price_per_share":0.16220338983050847,"price_display":"0.16","price_state":"stated","total_value":9570.0,"total_display":"9,570.00","total_whole":"9,570","shares_owned_after":2361377.0,"shares_owned_after_display":"2,361,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-28","filed_date":"2011-01-28","scope":"insider","n_lines":5},{"id":8870135,"accession":"0001299065-11-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001299065-11-000001","line_url":"/filing/0001299065-11-000001","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":0.1713157894736842,"price_display":"0.17","price_state":"stated","total_value":6510.0,"total_display":"6,510.00","total_whole":"6,510","shares_owned_after":2425377.0,"shares_owned_after_display":"2,425,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-27","filed_date":"2011-01-28","scope":"insider","n_lines":2},{"id":7268014,"accession":"0001299065-10-000007","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001299065-10-000007","line_url":"/filing/0001299065-10-000007","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155000.0,"shares_display":"155,000","price_per_share":0.19812903225806452,"price_display":"0.20","price_state":"stated","total_value":30710.0,"total_display":"30,710.00","total_whole":"30,710","shares_owned_after":2458377.0,"shares_owned_after_display":"2,458,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2010-12-20","scope":"insider","n_lines":3},{"id":7268009,"accession":"0001299065-10-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001299065-10-000007","line_url":"/filing/0001299065-10-000007","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":0.21511111111111111,"price_display":"0.22","price_state":"stated","total_value":9680.0,"total_display":"9,680.00","total_whole":"9,680","shares_owned_after":2634377.0,"shares_owned_after_display":"2,634,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-20","scope":"insider","n_lines":3},{"id":7750084,"accession":"0001299065-10-000005","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001299065-10-000005","line_url":"/filing/0001299065-10-000005","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":1.9941862068965517,"price_display":"1.99","price_state":"stated","total_value":11566.28,"total_display":"11,566.28","total_whole":"11,566","shares_owned_after":2659877.0,"shares_owned_after_display":"2,659,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-14","filed_date":"2010-01-21","scope":"insider","n_lines":12},{"id":7750061,"accession":"0001299065-10-000005","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001299065-10-000005","line_url":"/filing/0001299065-10-000005","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":2.07825,"price_display":"2.08","price_state":"stated","total_value":8313.0,"total_display":"8,313.00","total_whole":"8,313","shares_owned_after":2664677.0,"shares_owned_after_display":"2,664,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-12","filed_date":"2010-01-21","scope":"insider","n_lines":7},{"id":9282635,"accession":"0001299065-10-000004","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001299065-10-000004","line_url":"/filing/0001299065-10-000004","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":5850.0,"total_display":"5,850.00","total_whole":"5,850","shares_owned_after":2669677.0,"shares_owned_after_display":"2,669,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2010-01-06","scope":"insider","n_lines":4},{"id":6052869,"accession":"0001299065-09-000004","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001299065-09-000004","line_url":"/filing/0001299065-09-000004","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":4680.0,"total_display":"4,680.00","total_whole":"4,680","shares_owned_after":2669677.0,"shares_owned_after_display":"2,669,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-24","filed_date":"2009-12-28","scope":"insider","n_lines":3},{"id":9282644,"accession":"0001299065-10-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001299065-10-000004","line_url":"/filing/0001299065-10-000004","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":2.359916666666667,"price_display":"2.36","price_state":"stated","total_value":28319.0,"total_display":"28,319.00","total_whole":"28,319","shares_owned_after":2678677.0,"shares_owned_after_display":"2,678,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2010-01-06","scope":"insider","n_lines":9},{"id":6052860,"accession":"0001299065-09-000004","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001299065-09-000004","line_url":"/filing/0001299065-09-000004#line-11","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":4820.0,"total_display":"4,820.00","total_whole":"4,820","shares_owned_after":2672777.0,"shares_owned_after_display":"2,672,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider"},{"id":6052857,"accession":"0001299065-09-000004","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001299065-09-000004","line_url":"/filing/0001299065-09-000004#line-10","is_derivative":false,"issuer_cik":"0001299065","issuer_name":"Molecular Insight Pharmaceuticals, Inc.","issuer_ticker":"MIPI","issuer_name_source":null,"issuer_url":"/issuer/0001299065","owner_cik":"0001299065","owner_name":"Barlow David S","owner_display_name":"Barlow David S","owner_url":"/insider/0001299065","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":2674777.0,"shares_owned_after_display":"2,674,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider"}],"collapsed":true,"next_cursor":"2009-12-23|6052857","ledger_fault":false,"count":{"value":133,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":116,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":133},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001340752","name":"Molecular Insight Pharmaceuticals, Inc.","url":"/issuer/0001340752","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":9,"first_seen":"2007-11-21","last_seen":"2011-01-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001288379","name":"NEW RIVER PHARMACEUTICALS INC","url":"/issuer/0001288379","role":"Director","n_filings":6,"first_seen":"2005-08-23","last_seen":"2007-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001299065","retrieved_at":"2026-08-23T18:48:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}